Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
16.28
+0.49 (3.10%)
At close: Sep 2, 2026, 4:00 PM EDT
16.32
+0.04 (0.25%)
Pre-market: Sep 3, 2026, 8:51 AM EDT
Generate Biomedicines Earnings Call Transcripts
Fiscal Year 2026
-
The platform integrates advanced computational and experimental methods to accelerate novel protein drug discovery, with a lead anti-TSLP antibody in phase III for severe asthma and a robust oncology pipeline. Strategic partnerships and a focus on biannual dosing aim to improve compliance and market impact.